multipl
sclerosi
chronic
inflammatori
demyelin
diseas
central
nervou
system
cn
remain
major
caus
disabl
sever
studi
demonstr
ms
lesion
contain
multipl
leukocyt
cell
type
includ
lymphocyt
macrophag
dendrit
cell
believ
contribut
lesion
format
variou
distinct
interact
mechan
among
leukocyt
subset
infiltr
macrophag
identifi
major
effector
demyelin
ms
anim
model
ms
accord
studi
recent
describ
predomin
mechan
demyelin
ms
find
stimul
intens
interest
variou
effector
function
macrophag
lesion
format
includ
signal
event
draw
cell
cn
white
matter
trigger
effector
mechan
cell
destroy
myelin
instanc
macrophag
identifi
major
respond
cn
chemokin
produc
number
proinflammatori
cytokin
chemokin
toxic
molecul
known
promot
demyelin
major
cell
involv
phagocytosisdegrad
myelin
sheath
interestingli
leukocyt
cn
plaqu
ms
patient
contain
activ
transcript
factor
like
lead
enhanc
express
inflammatori
effector
function
macrophag
base
previou
work
propos
modul
inflammatori
signal
via
multipl
transcript
pathway
may
defici
leukocyt
includ
inflammatori
macrophag
ms
patient
defici
respons
suscept
inflammatori
demyelin
process
within
cn
protein
tyrosin
phosphatas
two
domain
act
neg
regul
innat
acquir
immun
cytokin
signal
via
mice
genet
lack
motheaten
mice
display
myelin
defici
may
mediat
increas
innat
inflammatori
mediat
cn
furthermor
motheaten
mice
highli
suscept
experiment
induc
demyelin
diseas
taken
togeth
studi
indic
key
regul
inflamm
cn
may
relev
pathogenesi
ms
inde
other
report
express
function
defici
leukocyt
ms
patient
compar
normal
human
subject
shown
mice
uniqu
display
unusu
rapid
cn
demyelin
associ
extens
white
matter
cellular
infiltr
clinic
paralysi
within
first
week
theiler
murin
encephalomyel
viru
tmev
infect
compar
wild
type
litterm
recent
shown
mice
show
profound
predomin
infiltr
bloodderiv
macrophag
cn
follow
tmev
infect
macrophag
concentr
area
demyelin
importantli
macrophag
possess
inflammatori
profil
vivo
unusu
coactiv
correspond
respons
proinflammatori
gene
rapid
demyelin
model
propos
macrophag
possess
particularli
pronounc
demyelin
phenotyp
accordingli
macrophagemonocyt
deplet
clodron
liposom
result
signific
delay
onset
clinic
symptom
decreas
inflamm
demyelin
spinal
cord
mice
studi
suggest
import
regul
cn
inflammatori
demyelin
act
predominantli
control
recruit
macrophag
cn
broad
modul
macrophag
inflammatori
effector
function
light
recent
studi
demonstr
import
macrophag
mediat
demyelin
ms
recent
studi
mice
cite
becam
imper
character
inflammatori
profil
macrophag
ms
patient
compar
normal
subject
present
studi
demonstr
express
defici
macrophag
ms
patient
compar
normal
subject
correspond
defici
show
phosphoryl
activ
higher
macrophag
ms
patient
compar
normal
subject
accord
activ
sever
gene
import
inflammatori
demyelin
increas
macrophag
ms
patient
follow
cytokin
stimul
support
direct
role
defici
alter
macrophag
function
experiment
deplet
macrophag
normal
human
subject
use
sirna
result
increas
activ
transcript
factor
increas
inflammatori
gene
express
level
seen
macrophag
ms
patient
taken
togeth
propos
potenti
involv
mediat
augment
inflammatori
profil
macrophag
seen
ms
patient
contribut
pathogenesi
ms
patient
clinic
diagnos
multipl
sclerosi
suni
upstat
medic
univers
ms
clinic
establish
criteria
patient
select
receiv
diseas
modifi
treatment
like
glatiramir
acet
steroid
immunosuppress
agent
least
three
month
prior
donat
blood
studi
macrophag
cultur
obtain
patient
relaps
remit
rr
ms
mean
edss
score
normal
control
subject
patient
control
normal
subject
match
age
gender
biometr
data
subject
use
studi
shown
tabl
institut
review
board
suni
upstat
univers
approv
studi
patient
control
subject
grant
inform
consent
provid
blood
patient
normal
subject
donat
ml
blood
collect
heparinaz
tube
blood
dilut
hank
balanc
salt
solut
hbss
overlaid
onto
lymphocyt
separ
medium
cellgro
herndon
va
centrifug
ml
interfac
contain
pbmc
collect
wash
twice
hbss
adher
monocyt
cultur
week
rpmi
media
fetal
bovin
serum
gmcsf
previous
describ
medium
replenish
everi
day
nonadher
cell
remov
second
feed
day
experi
cell
cultur
addit
day
absenc
gmcsf
wash
twice
pb
adher
cell
lyse
stat
teltest
friendswood
tx
rna
analysi
ripa
buffer
protein
analysi
flow
cytometri
cell
detach
incub
edta
minut
degre
c
method
consist
yield
pure
macrophag
assess
morpholog
criteria
describ
express
monocyt
lineag
marker
determin
flow
cytometr
analysi
macrophag
ms
patient
normal
subject
cultur
week
gmcsf
remov
media
macrophag
treat
either
ngml
r
system
minneapoli
mn
lp
salmonella
minnesota
lp
sigmaaldrich
st
loui
mo
usa
dsrna
polyinosin
polycytidyl
acid
amersham
pharmacia
piscataway
nj
receiv
medium
alon
sirna
use
deplet
macrophag
normal
subject
macrophag
transfect
sirna
human
scrambl
sirna
dharmacon
chicago
il
concentr
cell
transfect
reagent
dharmafect
dharmacon
chicago
il
use
specifi
manufactur
cell
incub
transfect
medium
hour
medium
replac
complet
growth
medium
anoth
hr
cytokin
treatment
effect
sirna
lower
express
evalu
western
immunoblot
total
rna
isol
use
rna
rna
quantifi
spectrophotometr
total
rna
convert
cdna
briefli
total
rna
random
primer
invitrogen
carlsbad
ca
incub
degre
minut
revers
transcript
perform
use
superscript
ii
rt
enzym
invitrogen
carlsbad
ca
follow
specif
manufactur
cdna
dilut
water
use
quantit
realtim
pcr
use
sybr
green
kit
abgen
epson
uk
pcr
paramet
minut
degre
cycl
degre
second
degre
minut
abi
prism
appli
biosystem
foster
citi
ca
primer
use
nm
serial
dilut
cdna
contain
known
copi
number
gene
use
quantit
pcr
run
gener
standard
curv
relat
copi
number
threshold
amplif
cycl
gene
express
level
calcul
logarithm
amplif
phase
determin
initi
mrna
copi
number
use
standard
curv
amplif
gene
specif
fragment
confirm
examin
melt
peak
agaros
gel
electrophoresi
follow
primer
pair
use
studi
forwardtggcgtggcaggagaacag
revers
gcagttggtcacagagtagggc
promot
forward
tggcttccccctccctacag
reverseccctggttcttgcgactgg
promot
ii
forward
atctgaggcttagtccctgagc
revers
ctgaggtctcggtgaaaccac
forwardcgagggaccaatgtgggc
reversegggtgaggaggcttcaagacc
forwardcacttctgtggctgctgctc
reversegctttctggggacatttgc
forwardcagtgtgacaacagtgaccgac
reversegcaataaaagacagcaaggagc
forwardatcccgagagacccgctac
reversetgattcaccacctccagcac
arginas
forwardgacctgccctttgctgacatc
reversettgacttctgccaccttgcc
forwardgctcatagcagccaccttc
reversegcttctttgggacacttgc
caspas
forwardcatcctcaggctcagaagg
reversetgtgcggcttgacttgtc
forwardgcatctacggtttgctgtg
revers
actgctcatcaccccattc
gapdh
forwardaccaccatggagaaggc
reverseggcatggactgtggtcatga
whole
cell
extract
prepar
previous
describ
briefli
macrophag
rins
pb
lyse
ripa
buffer
protein
per
lane
electrophores
polyacrylamid
resolv
gel
electroblot
polyvinyliden
difluorid
pvdf
membran
millipor
corpor
burlington
membran
block
nonfat
dri
milk
hour
incub
upstat
lake
placid
ny
antibodi
follow
horseradish
peroxidas
conjug
rabbit
igg
antibodi
dako
corpor
carpinteria
ca
antiarginas
bd
bioscienc
san
diego
ca
follow
horseradish
peroxidas
conjug
mous
igg
antibodi
enhanc
chemiluminesc
amersham
life
scienc
inc
cleveland
oh
use
visual
reactiv
protein
band
xray
film
western
blot
protein
band
quantifi
base
pixel
densiti
use
scion
imag
softwar
analysi
activ
macrophag
treat
either
uml
ngml
respect
hour
cell
wash
twice
pb
incub
mm
edta
minut
degre
c
cell
detach
gentl
pipet
receiv
stock
formaldehyd
per
ml
fixat
incub
methanol
half
hour
permeabil
cell
intracellular
stain
cell
wash
twice
stain
media
contain
bsa
sodium
azid
pb
cell
resuspend
stain
media
incub
either
mous
igg
isotyp
control
becton
dickinson
mountain
view
ca
addit
level
total
phosphoryl
plu
unphosphoryl
concurr
analyz
fix
permeabil
cell
incub
overnight
either
rabbit
antitot
santa
cruz
ca
rabbit
antitot
upstat
biotechnolog
ny
rabbit
polyclon
igg
isotyp
control
cell
incub
hour
goat
antirabbit
secondari
antibodi
conjug
pe
invitrogen
carlsbad
ca
furthermor
fix
permeabil
cell
incub
overnight
either
rabbit
upstat
lake
placid
ny
rabbit
polyclon
igg
isotyp
control
cell
incub
hour
goat
antirabbit
secondari
antibodi
conjug
pe
invitrogen
carlsbad
ca
addit
sever
extracellular
marker
quantifi
flow
cytometri
cell
incub
becton
dickinson
mountain
view
ca
hour
room
temperatur
cell
analyz
lsrii
analyz
becton
dickinson
mountain
view
ca
mean
floresc
intens
mfi
record
dnabind
activ
analyz
use
transcript
factor
assay
kit
activ
motif
carlsbad
ca
follow
manufactur
instruct
previous
describ
briefli
nuclear
extract
prepar
macrophag
normal
subject
ms
patient
treat
media
alon
ng
lp
hour
protein
level
nuclear
extract
quantifi
bradford
assay
pierc
chemic
rockford
il
incub
plate
coat
oligonucleotid
contain
consensusbind
sequenc
bound
detect
primari
antibodi
hrpconjug
secondari
antibodi
appli
detect
bound
primari
antibodi
provid
basi
colorimetr
quantif
enzymat
product
measur
nm
refer
wavelength
nm
micropl
reader
quantifi
amount
serial
dilut
purifi
recombin
protein
measur
provid
calibr
curv
bind
absorb
specif
assay
test
addit
wild
type
mutat
consensu
oligonucleotid
competit
mutat
competit
control
well
addit
nuclear
extract
addit
wildtyp
consensu
oligonucleotid
complet
abolish
bind
level
cytokin
measur
use
r
system
duoset
elisa
kit
r
system
minneapoli
mn
follow
manufactur
protocol
amount
produc
measur
amount
nitrit
macrophag
supernat
macrophag
normal
subject
ms
patient
treat
either
media
alon
lp
supernat
mix
greiss
reagent
ratio
sigma
st
loui
mo
reaction
allow
proceed
min
time
absorb
quantifi
elisa
plate
reader
calibr
curv
gener
use
sodium
nitrit
use
calcul
amount
nitrit
present
macrophag
supernat
arginas
enzymat
activ
measur
previous
describ
briefli
cultur
macrophag
lyse
ripa
buffer
incub
mm
larginin
min
assay
stop
addit
sigma
st
loui
mo
ad
sampl
incub
min
urea
product
arginas
measur
optic
densiti
nm
histogram
contain
statist
mean
standard
error
valu
unless
otherwis
specifi
sampl
ms
patient
sampl
normal
subject
use
sirna
experi
sampl
macrophag
normal
human
subject
use
pvalu
gener
use
unpair
student
ttest
pvalu
group
display
histogram
pvalu
less
chosen
indic
statist
signific
two
sampl
mean
express
level
multipl
macrophag
marker
quantifi
flow
cytometri
cultur
macrophag
normal
subject
ms
patient
figur
cell
stain
signific
differ
level
express
observ
subject
group
figur
furthermor
examin
express
receptor
chemokin
marker
inflammatori
monocyt
importantli
macrophag
defici
mice
display
increas
level
macrophag
ms
patient
significantli
higher
level
compar
normal
subject
indic
msderiv
macrophag
rel
heighten
inflammatori
state
character
two
potenti
activ
marker
cell
analyz
antigen
determin
integrin
integrin
shown
import
traffick
adhes
phagocytosi
migrat
macrophag
inflammatori
site
integrin
express
significantli
higher
macrophag
ms
patient
compar
normal
subject
contrast
express
integrin
significantli
differ
macrophag
ms
patient
normal
subject
previous
describ
pbmc
ms
patient
decreas
express
compar
normal
subject
cultur
macrophag
ms
patient
significantli
lower
level
protein
normal
subject
measur
intracellular
flow
cytometri
figur
corrobor
find
level
protein
macrophag
measur
western
immunoblot
figur
averag
level
macrophag
ms
patient
half
level
cell
normal
subject
examin
whether
macrophag
ms
patient
display
defici
transcript
level
level
mrna
quantifi
use
primer
flank
code
region
gene
common
transcript
figur
mrna
level
macrophag
significantli
lower
ms
patient
compar
normal
subject
figur
furthermor
analysi
mrna
express
individu
subject
group
show
statist
signific
correl
either
age
gender
level
data
shown
order
determin
individu
contribut
two
known
transcript
express
level
macrophag
promot
ii
transcript
copi
number
measur
use
promoterspecif
rtpcr
primer
constitut
level
promot
transcript
significantli
lower
macrophag
ms
patient
compar
control
figur
hand
constitut
level
promot
ii
transcript
significantli
lower
macrophag
ms
patient
compar
control
figur
taken
togeth
conclud
macrophag
ms
patient
constitut
lower
level
protein
mrna
compar
normal
subject
furthermor
lack
promot
ii
transcript
primarili
respons
defici
regul
phosphoryl
sever
stat
enzymat
remov
phosphat
group
tyrosin
either
activ
cytokin
receptor
downstream
signal
molecul
thu
modul
stat
activ
transloc
nucleu
transcript
activ
respons
gene
sever
studi
show
stringent
modul
signal
molecul
shown
elev
ms
examin
activ
macrophag
ms
patient
figur
analysi
measur
level
total
unphosphoryl
plu
phosphoryl
tyrosin
phosphoryl
macrophag
use
intracellular
flow
cytometri
expect
macrophag
ms
patient
significantli
elev
constitut
phosphoryl
compar
macrophag
normal
subject
figur
contrast
differ
express
level
total
protein
figur
verifi
differ
observ
level
attribut
rel
phosphoryl
state
stain
cell
reveal
reciproc
express
pattern
lower
constitut
level
ms
patient
correl
higher
level
compar
macrophag
normal
subject
data
shown
furthermor
macrophag
treat
hour
induc
phosphoryl
determin
possibl
differ
activ
follow
engag
receptor
treatment
caus
higher
phosphoryl
macrophag
ms
patient
compar
normal
subject
figur
similar
result
obtain
macrophag
treat
anoth
cytokin
mediat
activ
via
data
shown
apart
sever
transcript
factor
elev
ms
patient
control
particular
tyrosin
phosphoryl
mediat
interferon
signal
found
elev
ms
patient
control
therefor
character
activ
measur
level
total
unphosphoryl
plu
phosphoryl
tyrosin
phosphoryl
macrophag
use
intracellular
flow
cytometri
differ
observ
total
protein
figur
constitut
although
higher
significantli
elev
macrophag
ms
patient
compar
normal
subject
figur
howev
hour
treatment
result
higher
phosphoryl
macrophag
ms
patient
compar
normal
subject
figur
taken
togeth
data
suggest
show
enhanc
cytokinemedi
activ
macrophag
ms
patient
accord
defici
rel
normal
subject
macrophag
anoth
import
transcript
factor
involv
pathogenesi
ms
notabl
activ
observ
inflammatori
macrophag
ms
cn
lesion
sever
report
document
neg
regul
therefor
import
examin
activ
macrophag
ms
patient
figur
macrophag
normal
subject
ms
patient
treat
medium
alon
lp
nuclear
extract
isol
allow
bind
consensu
oligonucleotid
sequenc
bound
detect
rela
specif
antibodi
quantifi
base
calibr
curv
gener
use
purifi
recombin
protein
constitut
bind
slightli
significantli
elev
macrophag
ms
patient
compar
normal
subject
figur
furthermor
treatment
either
n
lp
dramat
increas
bind
importantli
nuclear
extract
macrophag
ms
patient
show
significantli
increas
bind
compar
macrophag
normal
subject
addit
quantifi
secret
proinflammatori
cytokin
macrophag
ms
patient
compar
normal
subject
sinc
previous
shown
defici
lead
higher
express
cytokin
macrophag
cultur
hour
either
media
alon
tlr
ligand
supernat
analyz
presenc
figur
constitut
level
slightli
significantli
elev
supernat
macrophag
ms
patient
compar
normal
subject
furthermor
stimul
macrophag
lp
dsrna
result
substanti
induct
subject
group
induct
significantli
higher
macrophag
ms
patient
compar
normal
subject
data
demonstr
macrophag
ms
patient
display
enhanc
express
gene
constitut
stimul
tlr
ligand
cytokin
induc
order
determin
whether
increas
activ
macrophag
ms
patient
rel
normal
subject
correspond
heighten
express
respons
gene
mrna
level
sever
gene
quantifi
follow
treatment
sever
cytokin
figur
express
level
chemokin
particular
interest
mediat
traffick
matur
attract
lymphocyt
macrophag
area
cn
inflamm
substanti
induc
macrophag
follow
treatment
importantli
macrophag
ms
patient
show
significantli
higher
induct
compar
macrophag
normal
subject
figur
similar
result
obtain
macrophag
treat
data
shown
similarli
mrna
disintegrin
matrix
metalloproteinas
may
involv
demyelin
induc
higher
level
macrophag
ms
patient
compar
macrophag
normal
subject
follow
treatment
data
shown
taken
togeth
agreement
depress
level
macrophag
ms
patient
display
increas
activ
increas
express
gene
express
furthermor
control
activ
examin
express
gene
follow
cytokin
stimul
figur
chemokin
chemokin
previous
shown
elev
ms
highli
induc
moder
induc
lp
ms
macrophag
moreov
induc
significantli
higher
level
ms
macrophag
compar
normal
subject
macrophag
figur
similarli
caspas
enzym
involv
inflamm
significantli
induc
higher
level
ms
macrophag
compar
macrophag
normal
subject
figur
data
suggest
phosphoryl
gene
show
enhanc
activ
macrophag
ms
patient
compar
macrophag
normal
subject
moreov
sinc
bind
elev
macrophag
ms
patient
want
examin
whether
gene
elev
macrophag
ms
patient
therefor
quantifi
express
induc
chemokin
real
time
rtpcr
figur
gene
show
substanti
higher
induct
macrophag
ms
patient
compar
normal
subject
follow
treatment
either
lp
data
demonstr
activ
gene
elev
macrophag
ms
patient
compar
normal
subject
sever
report
mous
model
point
import
differ
macrophag
activ
profil
specif
type
inflammatori
diseas
recent
character
macrophag
profil
classic
activ
macrophag
display
increas
gene
includ
induc
nitric
oxid
synthas
ino
altern
activ
macrophag
display
increas
gene
includ
arginas
interestingli
usual
profound
antagon
differenti
toward
either
macrophag
activ
profil
dual
express
ino
arginas
seldomli
observ
use
paradigm
determin
whether
ms
macrophag
might
preferenti
skew
toward
either
profil
rel
normal
subject
examin
constitut
ino
mrna
express
nitric
oxid
product
show
differ
ms
normal
subject
macrophag
figur
moder
lp
substanti
induc
ino
mrna
express
product
macrophag
figur
importantli
macrophag
ms
patient
show
significantli
higher
ino
mrna
express
product
follow
cytokin
stimul
compar
macrophag
normal
subject
respect
constitut
arginas
express
found
higher
level
arginas
protein
mrna
enzymat
activ
ms
compar
normal
subject
macrophag
figur
moreov
macrophag
expos
cytokin
ms
macrophag
express
arginas
normal
subject
macrophag
data
indic
ms
macrophag
may
constitut
skew
toward
activ
profil
vitro
skew
may
reinforc
nonetheless
ms
macrophag
also
display
rel
normal
subject
macrophag
follow
exposur
cytokin
latter
indic
extrem
plastic
ms
macrophag
rel
normal
subject
macrophag
potenti
import
cytokin
milieu
determin
ultim
balanc
phenotyp
cell
examin
whether
decreas
level
directli
respons
transcript
factor
activ
inflammatori
gene
express
macrophag
macrophag
normal
subject
treat
sirna
acut
deplet
figur
first
observ
protein
substanti
deplet
macrophag
treat
sirna
compar
macrophag
treat
control
sirna
scrambl
sequenc
figur
accordingli
deplet
result
consider
increas
arginas
protein
figur
mrna
data
shown
investig
whether
lower
level
normal
human
macrophag
treat
sirna
led
enhanc
activ
deplet
result
signific
increas
constitut
phosphoryl
significantli
higher
induct
respons
treatment
figur
similar
result
obtain
macrophag
treat
anoth
cytokin
mediat
activ
via
data
shown
addit
although
deplet
result
signific
increas
constitut
phosphoryl
treatment
hour
induc
significantli
higher
level
deplet
macrophag
compar
control
macrophag
treat
scrambl
sirna
figur
valid
control
activ
examin
express
respons
gene
macrophag
normal
subject
treat
either
scrambl
sirna
sirna
gene
figur
arginas
data
shown
significantli
induc
higher
level
macrophag
follow
stimul
similarli
gene
figur
caspas
data
shown
induc
significantli
higher
level
deplet
macrophag
follow
treatment
taken
togeth
result
point
import
role
downmodul
proinflammatori
activ
human
macrophag
furthermor
examin
role
control
gene
human
macrophag
first
mrna
level
chemokin
figur
data
shown
induc
significantli
higher
level
macrophag
follow
lp
treatment
furthermor
secret
deplet
macrophag
significantli
higher
follow
lp
dsrna
stimul
compar
macrophag
treat
scrambl
sirna
figur
addit
lp
treatment
led
significantli
higher
product
macrophag
compar
macrophag
treat
scrambl
sirna
figur
taken
togeth
conclud
depress
level
f
h
human
macrophag
led
uniqu
coactiv
proinflammatori
gene
rel
normal
subject
macrophag
observ
heighten
figur
propos
ms
macrophag
may
inher
inflammatori
natur
multipl
sclerosi
anim
model
ms
intens
macrophag
infiltr
present
activ
demyelin
lesion
nmber
differentiationactiv
correl
diseas
sever
macrophag
mediat
myelin
phagocytosi
degrad
oligodendrogliopathi
axon
loss
cellmedi
process
secret
inflammatori
mediat
base
recent
report
increas
demyelin
activ
macrophag
meme
mice
key
question
whether
macrophag
ms
patient
display
similar
defect
modul
proinflammatori
cytokin
signal
may
contribut
activ
inflammatori
profil
demyelin
activ
therefor
analyz
express
function
possibl
caus
enhanc
macrophag
inflammatori
activ
ms
examin
monocytederiv
macrophag
ms
patient
normal
subject
reveal
defici
macrophag
ms
patient
interestingli
defici
correspond
diminish
express
promot
ii
transcript
suggest
specif
alter
promot
ii
function
ms
accordingli
macrophag
ms
patient
display
enhanc
activ
transcript
factor
previous
shown
modul
variou
cell
type
includ
mous
macrophag
turn
sever
gene
shown
play
role
mechan
inflammatori
demyelin
shown
higher
macrophag
ms
patient
regul
relev
present
find
pathogenet
mechan
ms
support
previou
report
activ
signal
molecul
cn
ms
subject
regul
instanc
phosphoryl
found
highli
express
ms
lesion
normal
appear
white
matter
ms
patient
leukocyt
ms
patient
furthermor
macrophag
mice
lack
show
increas
constitut
activ
heighten
level
gene
moreov
lack
lead
sever
macrophagemedi
cn
demyelin
follow
tmev
infect
thu
present
studi
suggest
activ
express
sever
gene
confirm
element
macrophag
may
function
signific
pathophysiolog
ms
exampl
chemokin
attract
inflammatori
cell
demyelin
lesion
elev
macrophag
ms
patient
express
chemokin
control
analysi
gene
show
matrix
metalloproteinas
elev
macrophag
ms
patient
control
express
proteinas
may
involv
pathogenesi
ms
sinc
mediat
proteolysi
extracellular
matrix
molecul
disrupt
blood
brain
barrier
promot
leukocyt
entri
brain
parenchyma
highli
express
macrophag
shown
hydrolyz
myelin
basic
protein
therefor
directli
contribut
demyelin
addit
arginas
gene
shown
constitut
elev
cn
mice
play
import
role
virusinduc
demyelin
diseas
also
arginas
inhibit
result
attenu
eae
onset
progress
interestingli
increas
level
arginas
ms
macrophag
might
make
cell
suscept
viral
infect
relev
ms
pathogenesi
although
mechan
arginas
activ
may
promot
inflammatori
demyelin
still
remain
elucid
role
ms
light
present
find
investig
apart
sever
transcript
factor
previous
shown
elev
ms
patient
control
particular
tyrosin
phosphoryl
mediat
interferon
signal
found
elev
ms
patient
control
agreement
studi
found
activ
enhanc
macrophag
ms
patient
follow
stimul
furthermor
gene
like
chemokin
caspas
elev
macrophag
ms
patient
consist
role
express
gene
thu
lower
level
seen
macrophag
ms
patient
may
lead
activ
gene
play
role
pathogenesi
ms
furthermor
transcript
factor
mediat
proinflammatori
cytokin
signal
elev
ms
pbmc
macrophag
ms
lesion
thu
may
import
mice
genet
lack
show
elev
activ
increas
induc
gene
cn
glia
hematopoiet
cell
therefor
imper
investig
whether
gene
elev
macrophag
ms
patient
chemokin
show
significantli
elev
induct
macrophag
ms
patient
compar
normal
subject
reflect
increas
bind
activ
observ
ms
macrophag
addit
inflammatori
cytokin
regul
secret
higher
level
macrophag
ms
patient
compar
macrophag
normal
subject
follow
lp
dsrna
stimul
signal
via
respect
activ
consid
macrophag
normal
subject
display
similar
inflammatori
profil
macrophag
ms
patient
like
defici
seen
macrophag
ms
patient
directli
respons
increas
inflammatori
profil
classif
macrophag
phenotyp
marker
may
import
consider
ms
sever
report
mous
model
point
import
differ
macrophag
activ
profil
specif
type
inflammatori
diseas
instanc
socal
classic
activ
macrophag
display
increas
respons
gene
shown
critic
erad
variou
intracellular
microb
caus
type
autoaggress
tissu
inflamm
rheumatoid
arthriti
convers
socal
altern
activ
macrophag
display
increas
gene
includ
arginas
may
import
erad
helminth
promot
allergictyp
inflammatori
diseas
importantli
usual
profound
antagon
differenti
toward
either
macrophag
activ
profil
dual
express
gene
rare
seen
possibl
distinct
prior
classif
present
studi
indic
macrophag
ms
patient
may
exhibit
abnorm
high
activ
either
depend
natur
cytokin
stimul
defici
may
allow
aberr
coactiv
respons
gene
ms
macrophag
especi
vivo
cell
may
simultan
expos
cytokin
inflammatori
natur
macrophag
may
uniqu
perhap
possess
correspond
enhanc
demyelin
capac
concurr
activ
normal
oppos
pathway
ms
macrophag
support
observ
pattern
gene
express
leukocyt
includ
macrophag
ms
increas
coexpress
gene
observ
ad
promot
broad
activ
phenotyp
macrophag
ms
report
show
high
level
cytokin
coexpress
ms
instanc
cultur
myeloid
dendrit
cell
rr
ms
patient
polar
tcell
induc
increas
level
accord
find
sever
studi
demonstr
plasma
leukocyt
csf
patient
activ
ms
show
concurr
increas
level
compar
normal
subject
high
level
plasma
cytokin
certainli
contribut
enhanc
transcript
factor
activ
previous
observ
freshli
isol
peripher
blood
cell
ms
patient
distinct
prior
studi
present
studi
exclus
employ
cultur
macrophag
ms
patient
normal
subject
offer
advantag
allow
stimul
cell
equal
amount
cytokin
therefor
examin
intrins
differ
cytokin
signal
therefor
apart
elev
cytokin
level
observ
ms
patient
studi
document
macrophag
ms
patient
display
enhanc
signal
respons
proinflammatori
cytokin
therefor
lack
may
respons
broad
inflammatori
profil
cell
anoth
question
aris
defici
observ
peripher
macrophag
ms
patient
might
manifest
cn
inflammatori
demyelin
ms
patient
one
possibl
persist
cn
virus
might
attract
macrophag
cn
lower
level
ms
macrophag
enhanc
migrat
demyelin
activ
cn
latter
support
studi
show
tmev
infect
mice
result
sever
cn
demyelin
exclus
macrophagemedi
furthermor
defici
macrophag
enhanc
respons
chemokin
includ
play
import
role
macrophagemedi
demyelin
anoth
possibl
macrophag
attract
cn
myelinspecif
autoimmun
event
macrophag
enter
cn
contribut
enhanc
fcgamma
receptor
mediat
myelin
phagocytosi
presenc
antibodi
complement
hypothes
indic
twostep
process
macrophag
precondit
tissu
specif
inflamm
trigger
cn
specif
inflammatori
signal
latter
consist
recent
mous
studi
defici
alon
result
inflammatori
diseas
rather
establish
permiss
state
microbi
infect
trigger
inflamm
autoimmun
two
distinct
promot
drive
express
two
differ
transcript
gene
demonstr
promot
ii
transcript
preferenti
express
hematopoet
cell
select
lower
macrophag
ms
patient
compar
normal
subject
question
thu
aris
potenti
genet
basi
defici
promot
ii
activ
ms
leukocyt
sever
studi
examin
contribut
genet
ms
except
weak
associ
popul
studi
shown
absolut
linkag
locu
chromosom
would
explain
widespread
defici
promot
ii
express
ms
patient
altern
mechan
need
consid
includ
epigenet
alter
promot
activ
inde
numer
report
document
downregul
promot
ii
transcript
leukemialymphoma
cell
line
attribut
defici
epigenet
methyl
particular
cpg
site
promot
ii
interestingli
context
ms
either
viral
infect
inflamm
caus
de
novo
methyl
hypermethyl
cpg
promot
sequenc
result
decreas
gene
express
furthermor
recent
studi
report
associ
cn
demyelin
diseas
known
hamtsp
associ
myelopathytrop
spastic
paparparesi
profoundli
specif
suppress
express
methyl
promot
ii
accord
report
preliminari
data
indic
treatment
pmbc
ms
patient
demethyl
agent
increas
promot
ii
transcript
normal
level
person
unpublish
observ
whether
stabl
epigenet
modif
promot
ii
anoth
mechan
result
defici
express
macrophag
ms
patient
requir
investig
